WORLD LEADER IN MEDICAL CANNABIS TIKUN OLAM Europe, whose Hebrew name means "Repair the World", was born in 2005 in Israel, as a charitable Organization with the mission to "Repair the World" with innovative medicinal cannabis products. With more than 15 years of clinical and laboratory studies and an extensive database of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on exclusive medical cannabis strains which are protected by international intellectual property rights. TIKUN's presence in Europe begins in 2022, in Greece, taking advantage of the country's potential to develop into an international hub producing medicinal cannabis products, with most of those targeting exports to European countries. TIKUN OLAM Europe is a pharmaceutical company. With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN OLAM Europe has created the largest, in this sector, production unit in Europe, with a vertically integrated production process and a fully equipped R&D department, accommodated in state-of-the-art GMP facilities with cutting-edge equipment. The founding of TIKUN OLAM Europe is an important milestone in the history of the Tikun family. Staying true to the vision of Tikun, our Company responds to the growing needs of the European market both in terms of therapeutic applications with medical cannabis as well as in promoting holistic, natural balance & homeostasis through the integrated Tikun CBD product line.